Quillivant XR (methylphenidate extended release oral suspension) / Pfizer  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Quillivant XR (methylphenidate extended release oral suspension) / Pfizer
DS+ADHD Pilot, NCT04219280: Evaluating Treatment of ADHD in Children With Down Syndrome

Recruiting
4
100
US
Quillivant XR, Placebo
Children's Hospital Medical Center, Cincinnati, University of California, Davis
Down Syndrome, ADHD
09/25
09/25
NCT04419272 / 2012-004406-10: Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits

Recruiting
4
226
US
Methylphenidate, Concerta, Ritalin, Daytrana, Aptensio XR, Metadate CD, Methylin, Quillivant XR, Jornay PM, Adhansia XR, Cotempla, Placebo, sugar pill, lactose
VA Office of Research and Development, VA New York Harbor Healthcare System, Portland VA Medical Center, Miami VA Healthcare System, VA Boston Healthcare System
Epilepsy
09/27
09/27

Download Options